verified SJR 1,255 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q1 — Drug Discovery lock Subscription

Expert Review of Vaccines

Expert Review of Vaccines is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 112. It has a price of 4000 €. It has an SJR impact factor of 1,255 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,255.

Expert Review of Vaccines focuses its scope in these topics and keywords: vaccines, vaccine, diseases, pcv, neglected, epitope, achievements, responses, considerations, papillomavirus, ...

ISSN: 1476-0584

Publisher: Taylor and Francis Ltd.

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,255 Q1

H-index 112

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.000 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,255

H-index

112

Docs (year)

Docs 3y

425

Total refs

6234

Cites 3y

1960

Citable 3y

370

Cites/Doc 2y

4.48

Ref/Doc

76.02

Immediate OA

4000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical trials: consent in children

What next for botulism vaccine development?

Epidemiologic, immunologic and practical considerations in developing and evaluating a human hookworm vaccine

Emerging issues in vaccine economics: perspectives from the USA

DNA vaccines for poultry: the jump from theory to practice

Developmental immunology and vaccines:Cellular immune development and future vaccine strategies

Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report

Design of tuberculosis vaccine trials under financial constraints

Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer

Current status and future prospects for a vaccine against schistosomiasis

Current progress in enteropathogenic and enterohemorrhagic Escherichia coli vaccines

CpG DNA as a vaccine adjuvant

SHOW MORE ARTICLES

Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups

A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed

Challenges of antibody-mediated protection against HIV-1

Challenges in improving influenza vaccine protection in the elderly

CanNeisseria lactamicaantigens provide an effective vaccine to prevent meningococcal disease?

Can nonliving nasal vaccines be made to work?

BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control

Are we ready for pandemic influenza H5N1?

An overview of FDA-approved vaccines & their innovators

An oral bait vaccination approach for the Tasmanian devil facial tumor diseases

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine

Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?

FAQs

Expert Review of Vaccines has an SJR of 1,255 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4000 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Expert Review of Vaccines is 25%.

Expert Review of Vaccines

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Review of Vaccines?

What is the APC / publication cost?

What is the acceptance rate?